PRTN3 and rheumatoid arthritis: Moreover, RA patients who do not respond to treatment often experience increased disease progression, greater loss of functionality, worse prognosis, and elevated ACPA concentrations, consistent with our findings [10,28,29,61,62,63,64,65].